MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
59.02
-1.92 (-3.15%)
Sep 11, 2026, 4:00 PM EDT - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $2.84 billion as of September 11, 2026. Its market cap has increased by 724.67% in one year.
Market Cap
2.84B
Enterprise Value
2.43B
1-Year Change
724.67%
Ranking
Category
Stock Price
$59.02
ChartMarket Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $2.84B, an increase of 457.71%. That is a compound annual growth rate of 136.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 2.84B | 100.70% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| uniQure | 3.09B |
| Arcutis Biotherapeutics | 3.00B |
| Celldex Therapeutics | 2.90B |
| Immunome | 2.80B |
| Structure Therapeutics | 2.76B |
| AtaiBeckley | 2.73B |
| NewAmsterdam Pharma Company | 2.73B |
| Zai Lab | 2.71B |